AEHRA: AEHRA, ITALY’S FIRST PURE EV BRAND, REVEALS MODEL NAMES AND FUNDING PLANS
6.8.2024 16:00:24 CEST | news aktuell GmbH | Press release
- Impeto (SUV) and Estasi (sedan) represent AEHRA’s mission to craft works of pure Italian ‘automotive art’: beautiful, fiercely innovative and able to evoke strong emotions
- Start of factory construction scheduled for mid-2025; start of production of AEHRA SUV and Sedan by mid-2026
- AEHRA invited to attend summit on future of automotive industry chaired by Minister of Enterprise and Made in Italy, Rome, 7 August
Milan, 5th August 2024 – AEHRA has revealed the names of its first two models, – the Impeto SUV and the Estasi Sedan. As a testament to their mission to craft expressions of pure Italian automotive art, the AEHRA Impeto SUV takes its name from the emotion ‘impetus’, celebrating the overwhelming surge of creative energy. The Estasi Sedan is named for the emotion ‘ectasis’, an intense rapture deriving from the contemplation of an object’s beauty. These vehicles will fuse cutting-edge EV technology with breathtaking beauty.
The company has submitted a €1.2 billion development plan to the Ministry of Industry and Made in Italy, which controls Italy’s Automotive Fund, for the construction of a state-of-the-art manufacturing facility.
The Italian government’s potential endorsement of AEHRA’s funding application underlines the national strategic importance the brand will play in delivering sustainability at scale. AHERA has in fact been invited to a summit on the future of the Italian and European automotive industry at the Ministry of Enterprise and Made in Italy on 7 August in Rome.
Hazim Nada, AEHRA Founder & CEO, commented: “It will be immensely gratifying to have our application for funding endorsed by the Italian government and to be selected as a project of national strategic importance. This will further validate AEHRA’s mission to redefine ultra-high premium sustainable mobility by exploiting the latest engineering, battery, and manufacturing technologies.”
AEHRA will build a manufacturing campus at Mosciano Sant’ Angelo in Abruzzo, creating 540 new jobs and an additional 110 in Milan, and will commence production of its first two models by mid-2026, scaling to 25,000 per model per annum.
For further information: media@aehra.com - www.aehra.com
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Grünenthal strengthens its Genetic Medicine Capabilities and joins the Cluster for Nucleic Acid Therapeutics Munich16.7.2026 10:42:31 CEST | Press release
Aachen, Germany, 16 July 2026 – Grünenthal announced today that the company has joined the Cluster for Nucleic Acid Therapeutics Munich (CNATM), a Munich-centred innovation network that brings together leading universities, research institutions, biotech companies and industry partners to accelerate next-generation nucleic acid therapeutics into innovative treatments that can make a meaningful difference for patients
They’re really going for it: emporia launches the first 5G smartphone with a screen warranty15.7.2026 08:40:22 CEST | Press release
Better safe than sorry: the emporiaSMART.8 with Smartcover and rubber protectors
FEV collaborates with Microsoft on efficient AI model approach for in car applications built on NVIDIA9.7.2026 11:05:00 CEST | Press release
Aachen – FEV is collaborating with Microsoft to integrate powerful, in-vehicle Generative AI capabilities built on NVIDIA GPU-accelerated compute and AI model microservices. The cooperation aims to enable multimodal voice, text, and gesture interactions directly in the vehicle – independent of a permanent Internet connection.
Acrobat Studio og Acrobat KI-assistent: den nye generasjonen KI-støttet produktivitet – nå også på norsk8.7.2026 15:08:48 CEST | Press release
SAN JOSE, Calif. - 8. juli 2026 - Adobe utvider tilgjengeligheten til Acrobat Studio og Acrobat KI-assistenten i Norge. Nå er de KI-støttede funksjonene for produktivitet og kreavtivitet også tilgjengelige på norsk, og kan dermed brukes av brukere på lokalt språk. Acrobat Studio kombinerer Adobe Acrobat Pro, Adobe Express Premium og smarte KI-assistenter. Acrobat KI-assistent er også tilgjengelig som et separat tillegg for alle Adobe Acrobat-produkter (Acrobat Reader, Acrobat Standard og Acrobat Pro) – et fleksibelt alternativ for alle som ønsker å bruke KI-støttede funksjoner kun når de arbeider med dokumenter. Begge disse tilbudene gjør det mulig for brukere å raskere samle inn informasjon i PDF-er og Office-dokumenter, opprette innhold og effektivisere arbeidsflyten. Acrobat Studio og Acrobat KI-assistenten markerer et viktig trinn i utviklingen av PDF-filen, som har blitt standarden for viktige dokumenter siden den ble lansert av Adobe i 1993. Acrobat utvikler seg fra et ledende pr
Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy8.7.2026 10:37:04 CEST | Press release
Aachen, 08 July 2026 – Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD).
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom